Advertisement

Applications in Esophageal and Gastric Cancer

  • Frank Zimmermann
  • Björn L. D. M. Brücher
Chapter
Part of the Medical Radiology book series (MEDRAD)

Keywords

Gastric Cancer Esophageal Cancer Clin Oncol Radiat Oncol Biol Phys Esophageal Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ajani JA, Ota DM, Jessup JM, et al. (1991) Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer 68:1501–1506PubMedCrossRefGoogle Scholar
  2. Ajani JA, Mansfield PF, Janjan N, et al. (2004) Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric adenocarcinoma. J Clin Oncol 22:2774–2780PubMedCrossRefGoogle Scholar
  3. Allal AS, Zwahlen D, Bründler MA, et al. (2005) Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trial. Int J Radiat Oncol Biol Phys 63:1286–1289PubMedCrossRefGoogle Scholar
  4. Allum W, Cunningham D, Weeden S on behalf of the NCRI Upper GI Clinical Study Group (2003) Perioperative chemotherapy in operable gastric and lower esophageal cancer. A randomized controlled trial (the MAGIC trial ISRCTN 93793971). Proc Am Soc Clin Oncol 998aGoogle Scholar
  5. Al Sarraf M, Martz K, Herskovic A, et al. (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277–284Google Scholar
  6. Ancona E, Ruol A, Santi S, et al. (2001) Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with respectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial or preoperative chemotherapy versus surgery alone. Cancer 91:2165–2174PubMedCrossRefGoogle Scholar
  7. Ando N, Iizuka T, Kakegawa T, et al. (1997) A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 114:205–209PubMedCrossRefGoogle Scholar
  8. Ando N, Iizuka T, Ide H, et al. (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study JCOG 9204. J Clin Oncol 21:4592–4596PubMedCrossRefGoogle Scholar
  9. Apinop C, Puttisak P, Preecha N (1994) A prospective study of combined therapy in esophageal cancer. Hepatology Gastroenterol 41:391–393Google Scholar
  10. Arnott SJ, Duncan W, Kerr GR, et al. (1992) Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 24:108–113PubMedCrossRefGoogle Scholar
  11. Baba M, Natsugoe S, Shimada M, et al. (2000) Prospective evaluation of preoperative chemotherapy in respectable squamous cell carcinoma of the thoracic esophagus. Dis Esophagus 13:136–141PubMedCrossRefGoogle Scholar
  12. Badwe RA, Sharma V, Bhansali MS, et al. (1999) The quality of swallowing for patients with operable esophageal carcinoma. Cancer 85:763–768PubMedCrossRefGoogle Scholar
  13. Bareiss D, Stabenow R, Müller R, et al. (2002) Aktuelle Epidemiologie des Ösophaguskarzinoms und des Kardiakarzinoms in Deutschland (German). Dtsch Med Wochenschr 127:1367–1374PubMedCrossRefGoogle Scholar
  14. Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Brit J Surg 85:840–844PubMedCrossRefGoogle Scholar
  15. Bedenne L, Michel P, Bouche O, et al. (2002) Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc Am Soc Clin Oncol No. 519Google Scholar
  16. Blazeby LM, Conroy T, Hammerlid E, et al. (2003) Clinical and psychometric validation of an EORTC questionaire module, the EORTC QLQ-OES 18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39:1384–1394PubMedCrossRefGoogle Scholar
  17. Bosset JF, Gignoux M, Triboulet JP, et al. (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161–167PubMedCrossRefGoogle Scholar
  18. Burmeister BH, Smithers BM, Gebski V, et al., Trans Tasman Radiation Oncology Group, Australasian Gastrointestinal Trials Group and Clinical Trials Centre (2005) Surgery alone versus chemoradiotherapy followed by surgery for respectable cancer of the esophagus: a randomised controlled phase III trial. Lancet Oncol 6:659–668PubMedCrossRefGoogle Scholar
  19. Chiu PW, Chan AC, Leung SF, et al. (2005) Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 9:794–802PubMedCrossRefGoogle Scholar
  20. Daly JM, Karnell LH, Menck HR (1996) National cancer data base report on esophageal carcinoma. Cancer 78:1820–1828PubMedCrossRefGoogle Scholar
  21. ESMO European Society of Medical Oncology Guidelines (2005). www.esmo.orgGoogle Scholar
  22. Earle CC, Maroun JA (1999) Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomized trials. Eur J Cancer 35:1059–1064PubMedCrossRefGoogle Scholar
  23. Fiorica F, Di Bona D, Schepis F, et al. (2004) Preoperative chemoradiotherapy for oesophageal cancer: a systemic review and meta-analysis. Gut 53:925–930PubMedCrossRefGoogle Scholar
  24. Fok M, Sham JST, Choy D, et al. (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113:138–147PubMedGoogle Scholar
  25. Fok M, McShane J, Law SYK, Wong J (1994) Prospective randomized study in the treatment of oesophageal carcinoma. Asian J Surg 17:223–229Google Scholar
  26. Gignoux M, Roussel A, Paillot B, et al. (1987) The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 11:426–432PubMedCrossRefGoogle Scholar
  27. Gunderson LL (2002) Gastric cancer-patterns of relapse after surgical resection. Semin Radiat Oncol 12:150–161PubMedCrossRefGoogle Scholar
  28. Hallissey MT, Dunn JA, Ward LC, Allum WH (1994) The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 343:1309–1312PubMedCrossRefGoogle Scholar
  29. Hartgrink HH, van de Velde CJ, Putter H, et al. (2004) Neoadjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol 30:643–649PubMedCrossRefGoogle Scholar
  30. Hermanek P (1999) Tumor of the gastrointestinal tract and the pancreas: histopathology, staging, and prognosis. Anticancer Res 19:2393–2396PubMedGoogle Scholar
  31. Hermans J, Bonenkamp JJ, Boon MC, et al. (1993) Adjuvant therapy after curative resection for gastric cancer: metaanalysis of randomized trials. J Clin Oncol 11:1441–1447PubMedGoogle Scholar
  32. Hironaka S, Ohtsu A, Boku N, et al. (2003) Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T (2-3) N (any) M (0) Squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425–433PubMedCrossRefGoogle Scholar
  33. Hosch SB, Stoecklein NH, Pichlmeier U, et al. (2001) Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 19:1970–1975PubMedGoogle Scholar
  34. Hundahl SA (2002) Staging, stage migration, and patterns of spread in gastric Cancer. Semin Radiat Oncol 12:141–149PubMedCrossRefGoogle Scholar
  35. Janunger KG, Hafstrom L, Glimelius B (2002) Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 168:597–608PubMedGoogle Scholar
  36. Kelsen D, Karpeh M, Schwartz G et al. (1996) Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 14:1818–1828PubMedGoogle Scholar
  37. Kok TC, van Lanschot J, Siersema PD, van Overhagen H, Tilanus HW, for the Rotterdam Esophageal Tumor Study Group (1997) Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial (abstract). Proc Am Soc Clin Oncol 16:277a, abstract 984Google Scholar
  38. Kollmannsberger C, Budach W, Stahl M, et al. (2003) Adjuvant radiochemotherapy using 5-FU/Folinacid/cisplatin +/-paclitaxel and radiation in patients with completely (R0) resected high-risk gastric cancer (UICC stages II-IV (M0): A phase II study of the AIO/ARO/ACO. Onkologie 26 Sonderheft 5:32–34Google Scholar
  39. Korst RJ, Altorki NK (2004) Imaging for esophageal tumors. Thorac Surg Clin 14:61–69PubMedCrossRefGoogle Scholar
  40. Kosho M, Esiashvillie N, Landry JC, et al. (2004) Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist 9:147–159CrossRefGoogle Scholar
  41. Kramling HJ, Willich N, Cramer C, et al. (1997) Early results of IORT in the treatment of gastric cancer. Front Radiat Ther Oncol 31:157–160PubMedGoogle Scholar
  42. Lagergren J, Bergstrom R, Lindgren A, Nyren O (2000) The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 85:340–346PubMedCrossRefGoogle Scholar
  43. Launois B, Delarue D, Campoin JP, Kerbaol M (1981) Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153:690–692PubMedGoogle Scholar
  44. Law S, Wong J (1997) The roles of multimodality treatment and lymphadenectomy in the management of esophageal cancer. Chin Med J (Engl). 110(11):819–825PubMedGoogle Scholar
  45. Law S, Wong KH, Kwok KF, et al. (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240:791–800PubMedCrossRefGoogle Scholar
  46. Lee JL, Park SI, Kim SB, et al. (2004) A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15:947–954PubMedCrossRefGoogle Scholar
  47. Le Prise E, Etienne PL, Meunier B, et al. (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73:1779–1784PubMedCrossRefGoogle Scholar
  48. Liao Z, Zhang Z, Jin J, et al. (2004) Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60:1484–1493PubMedCrossRefGoogle Scholar
  49. Lordick F, Siewert JR (2005) Recent advances in multimodal treatment for gastric cancer: a review. Gastric Cancer 8:78–85PubMedCrossRefGoogle Scholar
  50. Macdonald JS, Smalley SR, Benedetti J, et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730PubMedCrossRefGoogle Scholar
  51. Macdonald JS (2005) Role of post-operative chemoradiation in resected gastric cancer. J Surg Oncol 90:166–170PubMedCrossRefGoogle Scholar
  52. Maipang T, Vasinanukorn P, Petpichetchian C, et al. (1994) Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 56:191–197PubMedGoogle Scholar
  53. Malthaner RA, Wong RKS, Rumble B, Zuraw L, Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care (2004) Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Medicine 2:35–52PubMedCrossRefGoogle Scholar
  54. Mari E, Floriani I, Tinazzi A, et al. (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. Ann Oncol 11:837–843PubMedCrossRefGoogle Scholar
  55. Medical Research Council Oesophageal Cancer Working Party (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359:1727–1733CrossRefGoogle Scholar
  56. Minsky BD, Pajak TF, Ginsberg RJ, et al. (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial combined-modality therapy for esophageal cancer: highdose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174PubMedCrossRefGoogle Scholar
  57. Nygaard K, Hagen S, Hansen HS, et al. (1992) Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16:1104–1109PubMedCrossRefGoogle Scholar
  58. Ogata T, Araki K, Matsuura K, et al (1995) A 10-year experience of intraoperative radiotherapy for gastric carcinoma and a new surgical method of creating a wider irradiation field for cases of total gastrectomy patients. Int J Radiat Oncol Biol Phys 32:341–347PubMedCrossRefGoogle Scholar
  59. Ott K, Sendler A, Becker K, et al. (2003) Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Gastric Cancer 6:159–167PubMedCrossRefGoogle Scholar
  60. Patel M, Ferry K, Franceschi D, et al. (2004) Esophageal carcinoma: current controversial topics. Cancer Invest 22:897–912PubMedCrossRefGoogle Scholar
  61. Pouliquen X, Levard H, Hay JM, et al. (1996) 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Association for Surgical Research. Ann Surg 223:127–133PubMedCrossRefGoogle Scholar
  62. Rebecca WO, Richard MA (2003) Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 1.Google Scholar
  63. Schlag PM (1992) Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft für Onkologie der Deutschen Gesellschaft für Chirurgie Study Group. Arch Surg. 127(12):1446–1450PubMedGoogle Scholar
  64. Shi XH, Yao W, Liu T (1999) Late course accelerated fractionation in radiotherapy of esophageal carcinoma. Radiother Oncol 51:21–26PubMedCrossRefGoogle Scholar
  65. Siewert JR, Fink U, Sendler A, et al. (1997) Gastric cancer. Curr Probl Surg 34:835–939PubMedGoogle Scholar
  66. Skoropad VY, Berdov BA, Mardynski YS, Titova LN (2000) A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery in respectable gastric cancer. Eur J Surg Oncol 26:773–779PubMedCrossRefGoogle Scholar
  67. Skoropad V, Berdov B, Zagrebin V (2002) Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial. J Surg Oncol 80:72–78PubMedCrossRefGoogle Scholar
  68. Smalley SR, Gunderson L, Tepper J, et al. (2002) Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys 52:283–293PubMedCrossRefGoogle Scholar
  69. Songun I, Keizer HJ, Hermans J, et al. (1999) Chemotherapy for operable gastric cancer: results of the Dutch randomized FAMTX trial. The Dutch Gastric Cancer Group (DGCG). Eur J Cancer 35:558–562PubMedCrossRefGoogle Scholar
  70. Stahl M, Stuschke M, Lehmann N, et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317PubMedCrossRefGoogle Scholar
  71. Stein HJ, Brücher BL, Feith M, et al. (2000) Ösophaguskarzinom. In: Therapie gastrointestinaler Tumoren (German). Springer-Verlag, Berlin Heidelberg New York, pp 187–207Google Scholar
  72. Tachibana J, Yoshimura H, Kinugasa S, et al. (2003) Postoperative chemotherapy vs. chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. Eur J Surg Oncol 29:580–587PubMedCrossRefGoogle Scholar
  73. Teniere P, Hay JM, Fingerhut A, Fagniez PL (1991) Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 173:123–130PubMedGoogle Scholar
  74. Tierney J, Arnott SJ, Duncan W, et al. (Oesophageal Cancer Collaborative Group) (2005) Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev 4.Google Scholar
  75. UICC (2002) TNM classification of malignant tumours, 6th edn. (Sobin LH, Wittekind Ch, eds). Wiley & Sons, New YorkGoogle Scholar
  76. Urba SG, Orringer MB, Turrisi A, et al. (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313PubMedGoogle Scholar
  77. von Rahden BH, Stein HJ (2004) Therapy of advanced esophageal malignancy. Curr Opin Gastroentrol 20:391–396CrossRefGoogle Scholar
  78. Walsh TN, Noonan N, Hollywood D, et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467PubMedCrossRefGoogle Scholar
  79. Wang M, Gu XZ, Yin W, et al. (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16:325–327PubMedGoogle Scholar
  80. Wang Y, Shi XH, He SQ, et al. (2002) Comparison between continuous accelerated hyperfractionated and latecourse accelerated hyperfractionated radiotherapy for esophageal carcinoma. In J Radiat Oncol Biol Phys 54:131–136CrossRefGoogle Scholar
  81. Wong RKS, Malthaner RA, Zuraw L, Rumble RB, The Cancer Care Ontario Practice Guidelines Initiative Gastrointestinal Cancer Disease Site Group (2003) Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 55:930–942PubMedCrossRefGoogle Scholar
  82. Wilke H, Preusser P, Fink U, et al. (1989) Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 7:1318–1326PubMedGoogle Scholar
  83. Xiao ZF, Yang ZY, Liang J, et al. (2003) Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 75:331–336PubMedCrossRefGoogle Scholar
  84. Zhang ZX, Gu XZ, Yin WB, et al. (1998) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)-report on 370 patients. Int J Radiat Oncol Biol Phys 42:929–934PubMedCrossRefGoogle Scholar
  85. Zhao KL, Shi XH, Jiang GL, et al. (2005) Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study. Int J Radiat Oncol Biol Phys 62:1014–1020PubMedCrossRefGoogle Scholar
  86. Zieren HU, Muller JM, Jacobi CA, et al. (1995) Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomised study. World J Surg 19:444–449PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • Frank Zimmermann
    • 1
  • Björn L. D. M. Brücher
    • 2
  1. 1.Department of Radiation OncologyKlinikum rechts der Isar der Technischen Universität MünchenMunichGermany
  2. 2.Department of SurgeryKlinikum rechts der Isar der Technischen Universität MünchenMunichGermany

Personalised recommendations